Chemokines in hematopoiesis.

PubWeight™: 2.01‹?› | Rank: Top 2%

🔗 View Article (PMID 18043246)

Published in Curr Opin Hematol on January 01, 2008

Authors

Hal E Broxmeyer1

Author Affiliations

1: Department of Microbiology and Immunology, and Walther Oncology Center, Indiana University School of Medicine, 950 West Walnut Street, Indianapolis, IN 46202, USA. hbroxmey@iupui.edu

Articles citing this

Awakening dormant haematopoietic stem cells. Nat Rev Immunol (2010) 2.88

The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med (2011) 2.36

CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice. J Clin Invest (2010) 1.82

Wnt-inhibitory factor 1 dysregulation of the bone marrow niche exhausts hematopoietic stem cells. Blood (2011) 1.76

The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry. Blood (2009) 1.51

Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis. Blood (2009) 1.29

CD133 identifies a human bone marrow stem/progenitor cell sub-population with a repertoire of secreted factors that protect against stroke. Mol Ther (2009) 1.27

Upregulation of nascent mitochondrial biogenesis in mouse hematopoietic stem cells parallels upregulation of CD34 and loss of pluripotency: a potential strategy for reducing oxidative risk in stem cells. Cell Cycle (2010) 1.25

Extravasation of leukocytes in comparison to tumor cells. Cell Commun Signal (2008) 1.16

MiR-886-3p down regulates CXCL12 (SDF1) expression in human marrow stromal cells. PLoS One (2010) 1.09

Inhibition of p38 mitogen-activated protein kinase promotes ex vivo hematopoietic stem cell expansion. Stem Cells Dev (2011) 1.09

Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors. Clin Cancer Res (2011) 1.09

Advances in stem cell mobilization. Blood Rev (2014) 1.09

Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment. Cell Commun Signal (2012) 1.06

The role of CXCL12-CXCR4 signaling pathway in pancreatic development. Theranostics (2013) 1.01

MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias. Blood Cancer J (2011) 1.00

Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis. Blood (2013) 0.99

CXC chemokine receptor 4 expressed in T cells plays an important role in the development of collagen-induced arthritis. Arthritis Res Ther (2010) 0.99

The aryl hydrocarbon receptor: regulation of hematopoiesis and involvement in the progression of blood diseases. Blood Cells Mol Dis (2010) 0.99

Inhibition of gluconeogenesis in primary hepatocytes by stromal cell-derived factor-1 (SDF-1) through a c-Src/Akt-dependent signaling pathway. J Biol Chem (2008) 0.97

Homing of Mesenchymal Stem Cells. Transfus Med Hemother (2008) 0.97

Cathepsin X is secreted by human osteoblasts, digests CXCL-12 and impairs adhesion of hematopoietic stem and progenitor cells to osteoblasts. Haematologica (2010) 0.94

Hypercholesterolemia links hematopoiesis with atherosclerosis. Trends Endocrinol Metab (2012) 0.94

Chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells in self-gelling alginate discs reveals novel chondrogenic signature gene clusters. Tissue Eng Part A (2011) 0.93

A novel CXCR4 antagonist derived from human SDF-1beta enhances angiogenesis in ischaemic mice. Cardiovasc Res (2009) 0.93

Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients. Am J Hematol (2012) 0.91

G protein-coupled receptors as therapeutic targets for multiple sclerosis. Cell Res (2012) 0.90

FoxP3+ regulatory T cells restrain splenic extramedullary myelopoiesis via suppression of hemopoietic cytokine-producing T cells. J Immunol (2009) 0.90

Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction. Obstet Gynecol Int (2013) 0.87

The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development. Nat Cell Biol (2015) 0.87

Exploiting the tumor microenvironment for theranostic imaging. NMR Biomed (2011) 0.85

The evolving biology of small molecules: controlling cell fate and identity. Philos Trans R Soc Lond B Biol Sci (2011) 0.85

Physiology and pharmacology of plerixafor. Transfus Med Hemother (2013) 0.85

Downregulation of CXCL12 signaling and altered hematopoietic stem and progenitor cell trafficking in a murine model of acute Anaplasma phagocytophilum infection. Innate Immun (2011) 0.85

CXCR4 expression in CD34+ cells and unit predominance after double umbilical cord blood transplantation. Leukemia (2012) 0.84

Homing of hematopoietic cells to the bone marrow. J Vis Exp (2009) 0.82

CXCR4-independent rescue of the myeloproliferative defect of the Gata1low myelofibrosis mouse model by Aplidin. J Cell Physiol (2010) 0.81

ApoE controls the interface linking lipids and inflammation in atherosclerosis. J Clin Invest (2011) 0.80

CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells. Blood (2016) 0.80

The hematopoietic chemokine CXCL12 promotes integration of human endothelial colony forming cell-derived cells into immature vessel networks. Stem Cells Dev (2014) 0.80

Dynamic Cross Talk between S1P and CXCL12 Regulates Hematopoietic Stem Cells Migration, Development and Bone Remodeling. Pharmaceuticals (Basel) (2013) 0.79

The role of chemokines in mediating graft versus host disease: opportunities for novel therapeutics. Front Pharmacol (2012) 0.79

Biodistribution of (137)Cs in a mouse model of chronic contamination by ingestion and effects on the hematopoietic system. Radiat Environ Biophys (2010) 0.78

Recruiting endogenous stem cells: a novel therapeutic approach for erectile dysfunction. Asian J Androl (2015) 0.78

Lessons from the Niche for Generation and Expansion of Hematopoietic Stem Cells. Drug Discov Today Ther Strateg (2009) 0.77

Requirement of CXCL12-CXCR7 signaling for CD20(-) CD138(-) double-negative population in lymphoplasmacytic lymphoma. Lab Invest (2016) 0.77

G-CSF maintains controlled neutrophil mobilization during acute inflammation by negatively regulating CXCR2 signaling. J Exp Med (2016) 0.77

Continuous AMD3100 Treatment Worsens Renal Fibrosis through Regulation of Bone Marrow Derived Pro-Angiogenic Cells Homing and T-Cell-Related Inflammation. PLoS One (2016) 0.76

Chemokine programming dendritic cell antigen response: part I - select chemokine programming of antigen uptake even after maturation. Immunology (2013) 0.76

The chemokine CX3CL1 (fractalkine) and its receptor CX3CR1: occurrence and potential role in osteoarthritis. Arch Immunol Ther Exp (Warsz) (2014) 0.76

Atypical matters in myeloid differentiation. Nat Immunol (2017) 0.75

Hierarchy of breast cancer cells: key to reverse dormancy for therapeutic intervention. Stem Cells Transl Med (2014) 0.75

ADCY7 supports development of acute myeloid leukemia. Biochem Biophys Res Commun (2015) 0.75

ACKR2: An Atypical Chemokine Receptor Regulating Lymphatic Biology. Front Immunol (2017) 0.75